Back to search
Epilepsy (Treatment Refractory)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Epilepsy (Treatment Refractory) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Epilepsy (Treatment Refractory) trials you may qualify forThe purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well capture…
The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well…
This is a phase II clinical trial in which children with refractory infantile spasms (also called epileptic spasms or West syndrome) will be treated with fenflu…
Background: \- Drug resistant epilepsy is the term used to describe epilepsy that cannot be controlled by medication. Many people whose seizures do not respond…
The aim of this study is to evaluate the clinical efficacy of everolimus as an adjunctive therapy for refractory epilepsy. The significance lies in addressing w…
The main goals of this clinical study are to learn if AMT-260 is safe and tolerable and works to reduce the frequency of seizures in adults with unilateral mesi…
Full Title: Fenfluramine for the treatment of refractory Epilepsy in Adult Dravet patients Short Title: Fenfluramine for Adult Dravet patients Clinical Phase:…
This is a multiple site, randomized, double blinded parallel-group controlled study. The purpose of this study is to evaluate efficacy, safety, and tolerability…
This is a parallel-arm, double-blind, placebo-controlled study with a screening phase that includes a 28-day run-in phase to establish baseline seizure frequenc…